Clinical trials
Phase 2 Cicatrix trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 5 |
| 2009 | 7 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Unknown status | 10 |
| Not yet recruiting | 3 |
| Recruiting | 2 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renovo | 12 |
| Pfizer | 6 |
| CUTISS AG | 3 |
| Capstone Therapeutics | 3 |
| RXi Pharmaceuticals, Corp. | 3 |
| Maternal and Child Health Hospital of Foshan | 2 |
| Beth Israel Deaconess Medical Center | 1 |
| Cell Therapy Ltd. | 1 |
| Geisinger Clinic | 1 |
| Halscion, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cicatrix | 48 |
| Cicatrix, Hypertrophic | 9 |
| Keloid | 8 |
| Fibrosis | 6 |
| Burns | 2 |
| Pathologic Processes | 2 |
| Arrhythmias, Cardiac | 1 |
| Cardiomyopathy, Hypertrophic | 1 |
| Hypopigmentation | 1 |
| Nevus | 1 |
Trials
Showing 51 to 48 of 48. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.